Ro15-4513 is a weak partial inverse agonist of the benzodiazepine class of drugs, developed by Hoffmann–La Roche in 1984, and is structurally related to the benzodiazepine antidote flumazenil.
3 edits since May 19, 2008. Last edited Jul 27, 2008 by Meodipt (143).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Ro15-4513. See this site's terms for details.